Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Lucid Diagnostics Inc (NQ: LUCD )

0.9909 -0.0091 (-0.91%)
Streaming Delayed Price Updated: 9:53 AM EST, Nov 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Lucid Diagnostics Inc

< Previous 1 2 Next >
LUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q1 2024
LUCD stock results show that Lucid Diagnostics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
3 Penny Stocks That Could Make a Big Comeback by the End of Q2
Although penny stocks to rebound represent one of the riskiest market categories, there could be some substance here. 
Via InvestorPlace
LUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q4 2023
LUCD stock results show that Lucid Diagnostics beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Earnings Preview: Lucid Diagnostics
Via Benzinga
Earnings Preview For Lucid Diagnostics
Via Benzinga
Where Lucid Diagnostics Stands With Analysts
Via Benzinga
Preview: Lucid Diagnostics's Earnings
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
A Glimpse of Lucid Diagnostics's Earnings Potential
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
LUCD Stock Earnings: Lucid Diagnostics Beats EPS, Misses Revenue for Q2 2024
LUCD stock results show that Lucid Diagnostics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
3 Hypergrowth Stocks That Speculators Should Keep Tabs On
While a high-risk proposition, these hypergrowth stocks can potentially bring enormous returns in a short period of time. 
Via InvestorPlace
Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for May 2024
Although the concept of penny stocks to buy is extremely risky, these ideas have the advantage of analysts’ positive assessments. 
Via InvestorPlace
Lucid Diagnostics Earnings Perspective: Return On Capital Employed
Via Benzinga
A Preview Of Lucid Diagnostics's Earnings
Via Benzinga
PAVmed, Lucid Diagnostics Pause Some Development Programs, Announce Layoffs
Via Benzinga
Earnings Scheduled For May 11, 2022
Companies Reporting Before The Bell • Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter. 
Via Benzinga
Earnings Scheduled For March 25, 2024
Companies Reporting Before The Bell • Bitcoin Depot (NASDAQ:BTM) is expected to report quarterly loss at $0.08 per share on revenue of $161.50 million. 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Earnings Scheduled For November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter. 
Via Benzinga
Earnings Scheduled For August 14, 2023
Companies Reporting Before The Bell • Safe & Green Holdings (NASDAQ:SGBX) is likely to report quarterly loss at $0.23 per share on revenue of $6.88 million. 
Via Benzinga
Why PAVmed Shares Are Falling Today
PAVmed Inc. (NASDAQ: PAVM) shares are trading lower after the company announced a workforce reduction of roughly 20% alongside other cost-cutting measures. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
  
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) stock rose 14.5% to $0.53 during Tuesday's after-market session. The company's market cap stands at $14.0 million. 
Via Benzinga
How Is The Market Feeling About Lucid Diagnostics Inc. - Common Stock?
Lucid Diagnostics Inc. - Common Stock's (NASDAQ:LUCD) short percent of float has fallen 4.35% since its last report. The company recently reported that it has 378.70 thousand... 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.